← 返回

长链非编码 RNA 在肿瘤免疫微环境中的作用

英文原题:The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.

查看英文原题

The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.

PubMed 2022/02/09(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤发生是由连续的遗传和表观遗传改变引起的复杂过程。过去几十年表明,免疫系统影响肿瘤发生、肿瘤进展和转移。尽管越来越多的免疫疗法被揭示,但其中只有一小部分有效。长链非编码RNA(lncRNA)是一类大于200个核苷酸的单链RNA分子,在肿瘤学和免疫学的分子网络中至关重要。越来越多的研究关注lncRNA与癌症免疫治疗之间的联系。然而,其深入机制仍不明确。在这篇综述中,我们概述了关于lncRNA在肿瘤免疫微环境中功能的最新研究。通过参与多种生物过程,如中性粒细胞募集、巨噬细胞极化、NK细胞细胞毒性和T细胞功能,lncRNA调控肿瘤发生、肿瘤侵袭、上皮-间质转化(EMT)和血管生成。此外,我们综述了目前对靶向lncRNA相关策略的理解。基于lncRNA的治疗可能代表有前景的方法,可作为癌症的预后生物标志物或潜在治疗靶点,为癌症诊断和治疗的未来研究与临床应用提供思路。

展开英文摘要原文

Tumorigenesis is a complicated process caused by successive genetic and epigenetic alterations. The past decades demonstrated that the immune system affects tumorigenesis, tumor progression, and metastasis. Although increasing immunotherapies are revealed, only a tiny proportion of them are effective.

Long non-coding RNAs (lncRNAs) are a class of single-stranded RNA molecules larger than 200 nucleotides and are essential in the molecular network of oncology and immunology. Increasing researches have focused on the connection between lncRNAs and cancer immunotherapy.

However, the in-depth mechanisms are still elusive. In this review, we outline the latest studies on the functions of lncRNAs in the tumor immune microenvironment. Via participating in various biological processes such as neutrophil recruitment, macrophage polarization, NK cells cytotoxicity, and T cells functions, lncRNAs regulate tumorigenesis, tumor invasion, epithelial-mesenchymal transition (EMT), and angiogenesis.

In addition, we reviewed the current understanding of the relevant strategies for targeting lncRNAs. LncRNAs-based therapeutics may represent promising approaches in serving as prognostic biomarkers or potential therapeutic targets in cancer, providing ideas for future research and clinical application on cancer diagnosis and therapies.

论文信息

作者
Guo Y、Xie Y、Luo Y
单位
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China.China
文献类型
非美国政府资助研究 · 综述
期刊
Frontiers in immunology2022
原文标识
PubMed 35222443 · DOI 10.3389/fimmu.2022.851004